SHARE
Depression Drugs Market

Depression Drugs - Global Market Outlook (2019 -2027)

5.0 (100 reviews)
Published: August 2020 ID: SMRC19840
5.0 (100 reviews)
Published: August 2020 ID: SMRC19840

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Depression Drugs Market is accounted for $12.38 billion in 2019 and is expected to reach $16.68 billion by 2027 growing at a CAGR of 3.8% during the forecast period. Some of the factors such as growing healthcare expenditure and increasing insurance coverage are anticipated to fuel the market growth. However, side effects associated with these drugs along with the availability of other treatment methods such as psychotherapy is hindering the market growth.

Depression drugs are medications used to treat major depressive disorders, some anxiety disorders, chronic pain conditions, and to help manage some addictions. Common side effects of depression drugs include dry mouth, weight gain, dizziness, headaches, and sexual dysfunction.

Based on the drug class, the serotonin and norepinephrine reuptake inhibitors (SNRIs) segment is likely to have a huge demand due to SNRIs help relieve depression symptoms, essentially sadness and irritability. These neurotransmitters are known to affect mood. Serotonin is also called a “feel-good” because it is accompanied by positive feelings of wellbeing. Norepinephrine is associated with alertness and energy. SNRIs help treat depression by maintaining the levels of these two neurotransmitters in the brain. They do this by discontinuing norepinephrine and serotonin from going back into the cells that released them.

By geography, North America is estimated to have a lucrative growth owing to high patient awareness levels regarding the availability of various drugs for depression, rising healthcare expenditure and the relatively larger number of R&D exercises on drug manufacturing and marketing, etc. these factors contribute for significant revenue generation from the region.

Some of the key players profiled in the Depression Drugs Market include Abbott, Allergan, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited, Pfizer, AstraZeneca, Bristol-Myers Squibb, Zhejiang NHU Company Ltd, and Sebela Pharmaceuticals.

Disease Types Covered:
• Generalized Anxiety Disorder
• Major Depressive Disorder
• Obsessive-Compulsive Disorders (OCD)
• Schizophrenia and Bipolar I Disorder
• Panic Disorder
• Other Disease Types
 
Drug Classes Covered:
• Atypical Antidepressants
• Selective Serotonin Reuptake Inhibitors (SSRIs)
• Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
• Tricyclic Antidepressants (TCAs)
• Anticonvulsants
• Beta-Blockers
• Norepinephrine-dopamine Reuptake Inhibitor (NDRI)
• Benzodiazepines
• Tetracyclic Antidepressants
• Monoamine Oxidase Inhibitors
• Central Nervous System (CNS) Stimulants

Distribution Channels Covered:
• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

Drug Types Covered:
• Branded Drugs
• Generic Drugs

Brands Covered:
• Zoloft
• Cymbalta
• Prozac
• Paxil
• Lexapro
• Prestiq
• Celexa

Applications Covered:
• Hospitals
• Prosthetic Clinics
• Rehabilitation Center
• Research Centres

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019 2020, 2024, and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary    
      
2 Preface
    
 2.1 Abstract    
 2.2 Stake Holders   
 2.3 Research Scope   
 2.4 Research Methodology  
  2.4.1 Data Mining  
  2.4.2 Data Analysis  
  2.4.3 Data Validation  
  2.4.4 Research Approach  
 2.5 Research Sources   
  2.5.1 Primary Research Sources 
  2.5.2 Secondary Research Sources 
  2.5.3 Assumptions  
      
3 Market Trend Analysis   
 3.1 Introduction   
 3.2 Drivers    
 3.3 Restraints   
 3.4 Opportunities   
 3.5 Threats    
 3.6 Application Analysis  
 3.7 Emerging Markets   
 3.8 Impact of Covid-19   
      
4 Porters Five Force Analysis   
 4.1 Bargaining power of suppliers  
 4.2 Bargaining power of buyers  
 4.3 Threat of substitutes  
 4.4 Threat of new entrants  
 4.5 Competitive rivalry   
      
5 Global Depression Drugs Market, By Disease Type 
 5.1 Introduction   
 5.2 Generalized Anxiety Disorder  
 5.3 Major Depressive Disorder  
 5.4 Obsessive-Compulsive Disorders (OCD) 
 5.5 Schizophrenia and Bipolar I Disorder 
 5.6 Panic Disorder   
 5.7 Other Disease Types  
  5.7.1 Elective Serotonin Reuptake Inhibitors (SSRIs)-Induced Disorder
  5.7.2 Attention Deficit Hyperactivity Disorder (ADHD)
      
6 Global Depression Drugs Market, By Drug Class 
 6.1 Introduction   
 6.2 Atypical Antidepressants  
 6.3 Selective Serotonin Reuptake Inhibitors (SSRIs)
 6.4 Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
 6.5 Tricyclic Antidepressants (TCAs) 
 6.6 Anticonvulsants   
 6.7 Beta-Blockers   
 6.8 Norepinephrine-dopamine Reuptake Inhibitor (NDRI)
 6.9 Benzodiazepines   
 6.10 Tetracyclic Antidepressants  
 6.11 Monoamine Oxidase Inhibitors 
 6.12 Central Nervous System (CNS) Stimulants
      
      
7 Global Depression Drugs Market, By Distribution Channel

 7.1 Introduction   
 7.2 Hospital Pharmacies  
 7.3 Online Pharmacies   
 7.4 Retail Pharmacies   
      
8 Global Depression Drugs Market, By Drug Type 
 8.1 Introduction   
 8.2 Branded Drugs   
 8.3 Generic Drugs   
      
9 Global Depression Drugs Market, By Brand 
 9.1 Introduction   
 9.2 Zoloft    
 9.3 Cymbalta    
 9.4 Prozac    
 9.5 Paxil    
 9.6 Lexapro    
 9.7 Prestiq    
 9.8 Celexa    
      
10 Global Depression Drugs Market, By Application 
 10.1 Introduction   
 10.2 Hospitals    
 10.3 Prosthetic Clinics   
 10.4 Rehabilitation Center  
 10.5 Research Centres   
      
11 Global Depression Drugs Market, By Geography 

 11.1 Introduction   
 11.2 North America   
  11.2.1 US   
  11.2.2 Canada   
  11.2.3 Mexico   
 11.3 Europe    
  11.3.1 Germany   
  11.3.2 UK   
  11.3.3 Italy   
  11.3.4 France   
  11.3.5 Spain   
  11.3.6 Rest of Europe  
 11.4 Asia Pacific   
  11.4.1 Japan   
  11.4.2 China   
  11.4.3 India   
  11.4.4 Australia   
  11.4.5 New Zealand  
  11.4.6 South Korea  
  11.4.7 Rest of Asia Pacific  
 11.5 South America   
  11.5.1 Argentina  
  11.5.2 Brazil   
  11.5.3 Chile   
  11.5.4 Rest of South America 
 11.6 Middle East & Africa  
  11.6.1 Saudi Arabia  
  11.6.2 UAE   
  11.6.3 Qatar   
  11.6.4 South Africa  
  11.6.5 Rest of Middle East & Africa 
      
12 Key Developments    
 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
 12.2 Acquisitions & Mergers  
 12.3 New Product Launch  
 12.4 Expansions   
 12.5 Other Key Strategies  
      
13 Company Profiling    
 13.1 Abbott
 13.2 Allergan    
 13.3 Eli Lilly and Company  
 13.4 GlaxoSmithKline   
 13.5 Johnson & Johnson   
 13.6 Novartis AG   
 13.7 Otsuka Pharmaceutical Co., Ltd., 
 13.8 Takeda Pharmaceutical Company Limited
 13.9 Pfizer    
 13.10 AstraZeneca   
 13.11 Bristol-Myers Squibb  
 13.12 Zhejiang NHU Company Ltd  
 13.13 Sebela Pharmaceuticals


List of Tables     
1 Global Depression Drugs Market Outlook, By Region (2018-2027) ($MN)
2 Global Depression Drugs Market Outlook, By Disease Type (2018-2027) ($MN)
3 Global Depression Drugs Market Outlook, By Generalized Anxiety Disorder (2018-2027) ($MN)
4 Global Depression Drugs Market Outlook, By Major Depressive Disorder (2018-2027) ($MN)
5 Global Depression Drugs Market Outlook, By Obsessive-Compulsive Disorders (OCD) (2018-2027) ($MN)
6 Global Depression Drugs Market Outlook, By Schizophrenia and Bipolar I Disorder (2018-2027) ($MN)
7 Global Depression Drugs Market Outlook, By Panic Disorder (2018-2027) ($MN)
8 Global Depression Drugs Market Outlook, By Other Disease Types (2018-2027) ($MN)
9 Global Depression Drugs Market Outlook, By Elective Serotonin Reuptake Inhibitors (SSRIs)-Induced Disorder (2018-2027) ($MN)
10 Global Depression Drugs Market Outlook, By Attention Deficit Hyperactivity Disorder (ADHD) (2018-2027) ($MN)
11 Global Depression Drugs Market Outlook, By Drug Class (2018-2027) ($MN)
12 Global Depression Drugs Market Outlook, By Atypical Antidepressants (2018-2027) ($MN)
13 Global Depression Drugs Market Outlook, By Selective Serotonin Reuptake Inhibitors (SSRIs) (2018-2027) ($MN)
14 Global Depression Drugs Market Outlook, By Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) (2018-2027) ($MN)
15 Global Depression Drugs Market Outlook, By Tricyclic Antidepressants (TCAs) (2018-2027) ($MN)
16 Global Depression Drugs Market Outlook, By Anticonvulsants (2018-2027) ($MN)
17 Global Depression Drugs Market Outlook, By Beta-Blockers (2018-2027) ($MN)
18 Global Depression Drugs Market Outlook, By Norepinephrine-dopamine Reuptake Inhibitor (NDRI) (2018-2027) ($MN)
19 Global Depression Drugs Market Outlook, By Benzodiazepines (2018-2027) ($MN)
20 Global Depression Drugs Market Outlook, By Tetracyclic Antidepressants (2018-2027) ($MN)
21 Global Depression Drugs Market Outlook, By Monoamine Oxidase Inhibitors (2018-2027) ($MN)
22 Global Depression Drugs Market Outlook, By Central Nervous System (CNS) Stimulants (2018-2027) ($MN)
23 Global Depression Drugs Market Outlook, By Distribution Channel (2018-2027) ($MN)
24 Global Depression Drugs Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
25 Global Depression Drugs Market Outlook, By Online Pharmacies (2018-2027) ($MN)
26 Global Depression Drugs Market Outlook, By Retail Pharmacies (2018-2027) ($MN)
27 Global Depression Drugs Market Outlook, By Drug Type (2018-2027) ($MN)
28 Global Depression Drugs Market Outlook, By Branded Drugs (2018-2027) ($MN)
29 Global Depression Drugs Market Outlook, By Generic Drugs (2018-2027) ($MN)
30 Global Depression Drugs Market Outlook, By Zoloft (2018-2027) ($MN)
31 Global Depression Drugs Market Outlook, By Cymbalta (2018-2027) ($MN)
32 Global Depression Drugs Market Outlook, By Prozac (2018-2027) ($MN)
33 Global Depression Drugs Market Outlook, By Paxil (2018-2027) ($MN)
34 Global Depression Drugs Market Outlook, By Lexapro (2018-2027) ($MN)
35 Global Depression Drugs Market Outlook, By Prestiq (2018-2027) ($MN)
36 Global Depression Drugs Market Outlook, By Celexa (2018-2027) ($MN)
37 Global Depression Drugs Market Outlook, By Application (2018-2027) ($MN)
38 Global Depression Drugs Market Outlook, By Hospitals (2018-2027) ($MN)
39 Global Depression Drugs Market Outlook, By Prosthetic Clinics (2018-2027) ($MN)
40 Global Depression Drugs Market Outlook, By Rehabilitation Center (2018-2027) ($MN)
41 Global Depression Drugs Market Outlook, By Research Centres (2018-2027) ($MN)
      
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials